Overview

Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia

Status:
Terminated
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Harvard Medical School
Harvard Medical School (HMS and HSDM)
Collaborators:
Commonwealth Research Center, Massachusetts
Dartmouth-Hitchcock Medical Center
National Institute of Mental Health (NIMH)
Novartis
Treatments:
Clozapine
Haloperidol
Haloperidol decanoate